London, UK – 9th December 2025. Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system ...

Detailed price information for Briacell Therapeutics Corp WT (BCTXW-Q) from The Globe and Mail including charting and trades.

Healthcare providers receive data from many disparate sources: hospitals, doctors’ offices, labs and lab machines, medical devices, pharmacies, and more. Investment in the correct infrastructure to ...

Clinical data archiving, the movement of inactive patient information from a production electronic health record (EHR) to a long-term storage solution, has been happening at major hospitals and health ...

BOSTON & PLEASANTON, Calif.--(BUSINESS WIRE)--One of the largest, most in-depth surveys of clinical data management professionals shows that the time it takes companies to design and release clinical ...

MILWAUKEE, WI, November 19, 2024 (EZ Newswire) -- As biopharmaceutical sponsors face increasing challenges in securing investigative sites for their clinical trials, the ability to reduce ...

In today's fast-paced and ever-evolving landscape of clinical trials, the ability to efficiently analyze and visualize data has become paramount. The vast amounts of data generated from these trials ...

A recent influx of digital technology has unlocked tremendous potential for clinical trials. For an industry that has traditionally relied on patients’ paper intake forms and manual data entry into ...

It is now a commonplace to propose high-dimensional molecular characterization within the translational research objectives of contemporary clinical trials. Similarly, most of these methods are being ...

- Zervimesine-treated participants tested 86% better on behavioral outcomes (NPI 12), 52% on activities of daily living, 91% on cognitive fluctuations, and 62% on motor symptoms as compared to placebo ...